GratXray AG
GratXray AG is a Swiss medical technology company developing innovative X-ray imaging systems for accurate and painless breast cancer diagnosis.
About
GratXray AG is a spin-off from ETH Zürich and PSI, focused on developing, manufacturing, and marketing advanced medical imaging systems based on phase contrast enhanced X-ray technology. Their patented method enables unprecedented contrast and tissue differentiation, particularly suited to soft tissue imaging where conventional X-ray systems are limited. Their main product, GI-BCT, is a grating interferometry-based breast computed tomography system that delivers true 3D volumetric imaging for accurate breast cancer detection without the need for compression or contrast agents, significantly improving both diagnostic accuracy and patient comfort. The company aims to revolutionize breast cancer care and diagnostics, reducing costs and improving outcomes for women, clinicians, and hospitals.
Products & Services
- Grating Interferometry Breast Computed Tomography (GI-BCT) system
- Phase contrast enhanced X-ray imaging technology
- Medical diagnostic imaging devices for breast cancer
Use Cases & Case Studies
- Early and accurate detection of breast tumors with high comfort and no need for compression
- Accurate imaging of both fatty and dense breast tissues
- Reduction in recall rates and healthcare costs through improved diagnostic accuracy
Partnerships & Collaborations
- ETH Zürich
- Paul Scherrer Institute (PSI)
Awards & Recognition
- SWISS INNOVATION award winner
- Top 100 Swiss Startup